Novan Shares Outstanding 2015-2019 | NOVN

Novan shares outstanding from 2015 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Novan Annual Shares Outstanding
(Millions of Shares)
2018 26
2017 16
2016 6
2015 2
2014 2
Novan Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 26
Q2 2019 26
Q1 2019 26
Q4 2018 26
Q3 2018 26
Q2 2018 26
Q1 2018 25
Q4 2017 16
Q3 2017 16
Q2 2017 16
Q1 2017 16
Q4 2016 6
Q3 2016 3
Q2 2016 2
Q1 2016 2
Q4 2015
Q3 2015 2
Q4 2014
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.053B $0.006B
Novan, Inc. is a pharmaceutical company. It engaged in the development and commercialization of therapies using its nitric oxide platform for dermatology. The Company's product candidates primarily include SB204, SB206, SB208 and SB414 which are in pre-clinical trial stage. It develops product through Nitricil technology(TM). Novan, Inc. is based in Durham, United States.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.496B 10.03
Zoetis (ZTS) United States $56.165B 33.60
Astellas Pharma (ALPMY) Japan $31.345B 15.66
Eisai (ESALY) Japan $18.870B 36.39
Merck (MKGAF) Germany $15.276B 20.85
Grifols, S.A (GRFS) Spain $14.913B 19.03
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.411B 491.52
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.953B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.244B 16.70
Jazz Pharmaceuticals (JAZZ) Ireland $7.843B 10.02
Sage Therapeutics (SAGE) United States $7.582B 0.00
Catalent (CTLT) United States $7.377B 30.01
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.134B 18.45
Arrowhead Pharmaceuticals (ARWR) United States $4.498B 103.13
United Therapeutics (UTHR) United States $3.968B 0.00
Nektar Therapeutics (NKTR) United States $3.457B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.363B 12.29
FibroGen (FGEN) United States $3.227B 94.85
Evotec AG (EVTCY) Germany $3.081B 50.42
PTC Therapeutics (PTCT) United States $2.693B 0.00
Portola Pharmaceuticals (PTLA) United States $2.117B 0.00
Xencor (XNCR) United States $2.041B 62.03
Tilray (TLRY) Canada $1.998B 0.00
Zogenix (ZGNX) United States $1.998B 0.00
Heron Therapeutics (HRTX) United States $1.943B 0.00
Corcept Therapeutics (CORT) United States $1.879B 22.83
Ironwood Pharmaceuticals (IRWD) United States $1.800B 57.40
Pacira Pharmaceuticals (PCRX) United States $1.791B 52.99
USANA Health Sciences (USNA) United States $1.560B 16.65
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.232B 20.33
Radius Health (RDUS) United States $1.108B 0.00
Endo (ENDP) Ireland $1.027B 1.89
Theravance Biopharma (TBPH) Cayman Islands $1.013B 0.00
Karyopharm Therapeutics (KPTI) United States $0.980B 0.00
ArQule (ARQL) United States $0.951B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.938B 0.00
Aerie Pharmaceuticals (AERI) United States $0.877B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.823B 5.61
Organogenesis Holdings (ORGO) United States $0.758B 0.00
TherapeuticsMD (TXMD) United States $0.743B 0.00
Flexion Therapeutics (FLXN) United States $0.614B 0.00
Collegium Pharmaceutical (COLL) United States $0.607B 0.00
Translate Bio (TBIO) United States $0.565B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
ChemoCentryx (CCXI) United States $0.513B 0.00
ImmunoGen (IMGN) United States $0.495B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.492B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.459B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.458B 55.50
Crinetics Pharmaceuticals (CRNX) United States $0.450B 0.00
OptiNose (OPTN) United States $0.433B 0.00
Dermira (DERM) United States $0.415B 0.00
Siga Technologies (SIGA) United States $0.402B 9.19
Akebia Therapeutics (AKBA) United States $0.400B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.392B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.389B 16.78
Recro Pharma (REPH) United States $0.389B 0.00
Indivior (INVVY) United States $0.387B 1.40
Ardelyx (ARDX) United States $0.386B 0.00
DURECT (DRRX) United States $0.373B 0.00
Innate Pharma SA (IPHYF) France $0.372B 0.00
Lannett Co Inc (LCI) United States $0.369B 4.29
Harpoon Therapeutics (HARP) United States $0.339B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.288B 0.00
GlycoMimetics (GLYC) United States $0.270B 0.00
Molecular Templates (MTEM) United States $0.268B 0.00
Xeris Pharmaceuticals (XERS) United States $0.222B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.209B 0.00
KalVista Pharmaceuticals (KALV) United States $0.197B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.193B 0.00
Nature's Sunshine Products (NATR) United States $0.188B 32.37
Calithera Biosciences (CALA) United States $0.188B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.187B 0.00
Jounce Therapeutics (JNCE) United States $0.174B 2.33
La Jolla Pharmaceutical (LJPC) United States $0.163B 0.00
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Concert Pharmaceuticals (CNCE) United States $0.160B 0.00
Aquestive Therapeutics (AQST) United States $0.150B 0.00
Redhill Biopharma (RDHL) Israel $0.137B 0.00
MEI Pharma (MEIP) United States $0.135B 0.00
Ocular Therapeutix (OCUL) United States $0.135B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.134B 0.00
CV Sciences (CVSI) United States $0.134B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.131B 0.00
IMV INC (IMV) Canada $0.126B 0.00
CannTrust Holdings (CTST) Canada $0.124B 0.00
Cardiome Pharma (CORV) Canada $0.115B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.092B 0.00
Majesco Entertainment (PTE) United States $0.089B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Aclaris Therapeutics (ACRS) United States $0.076B 0.00
Otonomy (OTIC) United States $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 22.05
Generex Biotechnology (GNBT) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.062B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.062B 0.00
Natural Alternatives (NAII) United States $0.061B 15.18
Genocea Biosciences (GNCA) United States $0.059B 0.00
Medicure (MCUJF) Canada $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.053B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.049B 0.00
Capnia (SLNO) United States $0.049B 0.00
Nivalis Therapeutics (ALPN) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
CTI BioPharma (CTIC) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
Jaguar Animal Health (JAGX) United States $0.031B 0.00
Mast Therapeutics (SVRA) United States $0.030B 0.00
Biomerica (BMRA) United States $0.029B 0.00
PharmAthene (ALT) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Vical (BBI) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00